In-hospital blood collection increases the rate of indeterminate results in interferon-gamma release assays
Background: The interferon (IFN)-γ release assay (IGRA) has recently been established as a method to evaluate the infection status of tuberculosis instead of the tuberculin skin test. However, indeterminate results can create challenges to interpretation. The IGRA has been available in Japan since 2...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-02-01
|
| Series: | Therapeutic Advances in Respiratory Disease |
| Online Access: | https://doi.org/10.1177/17534666221077817 |
| _version_ | 1797853336492310528 |
|---|---|
| author | Yuki Osakabe Fumihiro Yamaguchi Ayako Suzuki Haruka Kitano Mina Hiraiwa Yo Shiratori Shota Onozaki Mari Nakamoto Saori Kawamura Miku Kosuge Kenji Atarashi Hidekazu Cho Shohei Shimizu Akira Fujishima Yusuke Shikama |
| author_facet | Yuki Osakabe Fumihiro Yamaguchi Ayako Suzuki Haruka Kitano Mina Hiraiwa Yo Shiratori Shota Onozaki Mari Nakamoto Saori Kawamura Miku Kosuge Kenji Atarashi Hidekazu Cho Shohei Shimizu Akira Fujishima Yusuke Shikama |
| author_sort | Yuki Osakabe |
| collection | DOAJ |
| description | Background: The interferon (IFN)-γ release assay (IGRA) has recently been established as a method to evaluate the infection status of tuberculosis instead of the tuberculin skin test. However, indeterminate results can create challenges to interpretation. The IGRA has been available in Japan since 2005, including the recently launched QuantiFERON-TB Gold Plus (QFT-plus) assay. Objectives: The aim of this study was to investigate the clinical features and predictors of indeterminate results by the QFT-plus test in routine practice. Methods: This was a cross-sectional study of 1258 patients. Multivariate logistic regression models were employed to investigate the clinical factors related to indeterminate results by the QFT-plus. Results: Overall, 91.8% of results were found to be conclusive and 8.2% were indeterminate. The QFT-plus indeterminate results were predominantly due to a low level of IFN-γ production by mitogens. Multivariate analysis indicated that an indeterminate result was significantly associated with age, sex, corticosteroid use, autoimmune disease, and inpatient setting. Conclusion: Certain types of individuals are at higher risk of an indeterminate IGRA result. The QFT-plus test for hospitalized patients should be avoided as much as possible, and it is better to perform the test for those patients in outpatient settings. |
| first_indexed | 2024-04-09T19:47:54Z |
| format | Article |
| id | doaj.art-aa9bedf1a8bd45169582e6ae623652f0 |
| institution | Directory Open Access Journal |
| issn | 1753-4666 |
| language | English |
| last_indexed | 2024-04-09T19:47:54Z |
| publishDate | 2022-02-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Respiratory Disease |
| spelling | doaj.art-aa9bedf1a8bd45169582e6ae623652f02023-04-03T13:05:13ZengSAGE PublishingTherapeutic Advances in Respiratory Disease1753-46662022-02-011610.1177/17534666221077817In-hospital blood collection increases the rate of indeterminate results in interferon-gamma release assaysYuki OsakabeFumihiro YamaguchiAyako SuzukiHaruka KitanoMina HiraiwaYo ShiratoriShota OnozakiMari NakamotoSaori KawamuraMiku KosugeKenji AtarashiHidekazu ChoShohei ShimizuAkira FujishimaYusuke ShikamaBackground: The interferon (IFN)-γ release assay (IGRA) has recently been established as a method to evaluate the infection status of tuberculosis instead of the tuberculin skin test. However, indeterminate results can create challenges to interpretation. The IGRA has been available in Japan since 2005, including the recently launched QuantiFERON-TB Gold Plus (QFT-plus) assay. Objectives: The aim of this study was to investigate the clinical features and predictors of indeterminate results by the QFT-plus test in routine practice. Methods: This was a cross-sectional study of 1258 patients. Multivariate logistic regression models were employed to investigate the clinical factors related to indeterminate results by the QFT-plus. Results: Overall, 91.8% of results were found to be conclusive and 8.2% were indeterminate. The QFT-plus indeterminate results were predominantly due to a low level of IFN-γ production by mitogens. Multivariate analysis indicated that an indeterminate result was significantly associated with age, sex, corticosteroid use, autoimmune disease, and inpatient setting. Conclusion: Certain types of individuals are at higher risk of an indeterminate IGRA result. The QFT-plus test for hospitalized patients should be avoided as much as possible, and it is better to perform the test for those patients in outpatient settings.https://doi.org/10.1177/17534666221077817 |
| spellingShingle | Yuki Osakabe Fumihiro Yamaguchi Ayako Suzuki Haruka Kitano Mina Hiraiwa Yo Shiratori Shota Onozaki Mari Nakamoto Saori Kawamura Miku Kosuge Kenji Atarashi Hidekazu Cho Shohei Shimizu Akira Fujishima Yusuke Shikama In-hospital blood collection increases the rate of indeterminate results in interferon-gamma release assays Therapeutic Advances in Respiratory Disease |
| title | In-hospital blood collection increases the rate of indeterminate results in interferon-gamma release assays |
| title_full | In-hospital blood collection increases the rate of indeterminate results in interferon-gamma release assays |
| title_fullStr | In-hospital blood collection increases the rate of indeterminate results in interferon-gamma release assays |
| title_full_unstemmed | In-hospital blood collection increases the rate of indeterminate results in interferon-gamma release assays |
| title_short | In-hospital blood collection increases the rate of indeterminate results in interferon-gamma release assays |
| title_sort | in hospital blood collection increases the rate of indeterminate results in interferon gamma release assays |
| url | https://doi.org/10.1177/17534666221077817 |
| work_keys_str_mv | AT yukiosakabe inhospitalbloodcollectionincreasestherateofindeterminateresultsininterferongammareleaseassays AT fumihiroyamaguchi inhospitalbloodcollectionincreasestherateofindeterminateresultsininterferongammareleaseassays AT ayakosuzuki inhospitalbloodcollectionincreasestherateofindeterminateresultsininterferongammareleaseassays AT harukakitano inhospitalbloodcollectionincreasestherateofindeterminateresultsininterferongammareleaseassays AT minahiraiwa inhospitalbloodcollectionincreasestherateofindeterminateresultsininterferongammareleaseassays AT yoshiratori inhospitalbloodcollectionincreasestherateofindeterminateresultsininterferongammareleaseassays AT shotaonozaki inhospitalbloodcollectionincreasestherateofindeterminateresultsininterferongammareleaseassays AT marinakamoto inhospitalbloodcollectionincreasestherateofindeterminateresultsininterferongammareleaseassays AT saorikawamura inhospitalbloodcollectionincreasestherateofindeterminateresultsininterferongammareleaseassays AT mikukosuge inhospitalbloodcollectionincreasestherateofindeterminateresultsininterferongammareleaseassays AT kenjiatarashi inhospitalbloodcollectionincreasestherateofindeterminateresultsininterferongammareleaseassays AT hidekazucho inhospitalbloodcollectionincreasestherateofindeterminateresultsininterferongammareleaseassays AT shoheishimizu inhospitalbloodcollectionincreasestherateofindeterminateresultsininterferongammareleaseassays AT akirafujishima inhospitalbloodcollectionincreasestherateofindeterminateresultsininterferongammareleaseassays AT yusukeshikama inhospitalbloodcollectionincreasestherateofindeterminateresultsininterferongammareleaseassays |